| Application no. and date | 92924668.4 (espacenet) (Federated) (European Patent Register), 19921204 | | Patent/reg. no. and date | DK/EP 0616524, 19981007 | | Publication date | 19940928 | | Priority no. and date | GB 9126405, 19911212, GB 9202522, 19920206 | | EP pub. no. and date |
EP 0616524 19940928 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House,
Berkeley Avenue
Greenford,
Middlesex UB6 0NN, GB | | Applicant ref. no. | 4591 | | Inventor | AKEHURST, Rachel Ann, Glaxo Group Research Limited,
Park Road
Ware,
Hertfordshire SG12 0DP, GB,
TAYLOR, Anthony James, Glaxo Group Research Limited,
Park Road
Ware,
Hertfordshire SG12 0DP, GB,
WYATT, David Andrew, Glaxo Group Research Limited,
Park Road
Ware,
Hertfordshire SG12 0DP, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 9/00 (2006.01) | | Title | Lægemidler | | Int. application no. | EP1992002809 | | Int. publication no. | WO1993011744 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
